CTOR vs MTD · $105.2M cap vs P/E 27, rev $3.87B
Citius Oncology, Inc. (CTOR) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
CTOR does not have a complete income-statement cache yet.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
CTOR currently screens at market cap $105.2M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the CTOR and MTD stock pages for the full models.
Not investment advice.